Google Maps

NCT07713134

Overview

NCT ID: NCT07713134
Lead Sponsor: Tangshan Maternal and Child Health HospitalOTHER
Official Title: Efficacy and Safety of the Biased μ-Opioid Receptor Agonist Oliceridine in Hysteroscopic Procedures
Brief Summary: This study aimed to investigate the safety and efficacy of oliceridine compared with sufentanil in outpatient hysteroscopy.
Conditions: Hysteroscopy
Analgeisa
Interventions: Sufentanil
Oliceridine

Ages Eligible for Study: Adult (18-64)
Sexes Eligible for Study: Female
Accepts Healthy Volunteers?: No
Eligibility Criteria: Inclusion Criteria:

voluntary signing of the anesthesia informed consent form;

stable vital signs;

age between 18 and 60years;

American Society of Anesthesiologists (ASA) physical status I or II; and

body mass index (BMI) <30 kg/m²

Exclusion Criteria:

inability or unwillingness to sign the informed consent form;

known allergy to the study drug;

uncontrolled hypertension or diabetes mellitus;

significant central nervous system disease;

diagnosed psychiatric disorders;

use of anxiolytics, antidepressants, hypnotics, or sedatives within the past three months

Central Contacts: No data available
Locations: Tangshan Maternal and Child Health Hospital, Tangshan, Hebei 063000